Speaker Bios &
Learning Objectives
10:00
1. Confidently prescribe pregabalin to treat anxiety disorders for the right patients.
2. Discuss the evidence for ketamine in treatment resistant depression.
3. Evaluate the cost-effectiveness of lisdexamfetamine and describe its role in ADHD treatment.
10:30
1. Discuss evidence for novel obesity medications.
2. Describe the place in therapy for obesity therapies
3. Use shared-decision making to prescribe and monitor individualized obesity therapies
11:30
At the end of this session participants will be able to help patients use shared decision making surrounding:
1. The pros and cons of daily ASA for primary prevention.
2. The pros and cons of bisphosphonate holidays in osteoporosis.
3. When to encourage urate-lowering therapy in gout.
1:00
1. Discuss whether honey for coughs has therapeutic value.
2. Understand the FDA advisory on phenylephrine as an oral decongestant.
3. Outline the pros/cons of nicotine patch + IR formulation combinations for patients.
4. Determine if glucosamine and omega 3s now play a role in Arthritis and CV disease (respectively).
5. Quantify the amount of ‘extra’ water needed during psyllium use for Constipation
1:30
1. Select appropriate blood pressure and HgbA1C targets in older patients based on presence or absence of geriatric syndromes, including dementia and frailty.
2. Outline the benefits of anticoagulation in older adults with atrial fibrillation.
3. Discuss the evidence to guide decision making regarding anticoagulation for older adults in the context of falls.
Dr. Derek Jorgenson, BSP, PharmD
Amy Soubolsky, BSP, MSc
Dr. Brandon Suen, MD, FRCPC (General Internal Medicine), Diplo. Of ABOM
Zack Dumont, BSP, ACPR, MSc
Alex Crawley, BSP, ACPR
Eric Landry, BSP, ACPR
Dr. Shanna Fenton
Dr. Jeff Taylor, BSP, PhD
Dr. Megan Surkan
Erin Yakiwchuk, BSP, MSc